Malaria: Difference between revisions
From WikiDemocracy
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 275: | Line 275: | ||
[https://www.nature.com/articles/d44148-025-00245-8 by nature africa 15/8/25] | [https://www.nature.com/articles/d44148-025-00245-8 by nature africa 15/8/25] | ||
As malaria remains one of Africa’s most persistent public health threats, 2025 is poised to become a turning point in the fight against the disease, with numerous African countries set to expand vaccine coverage at unprecedented levels. | As malaria remains one of Africa’s most persistent public health threats, 2025 is poised to become a turning point in the fight against the disease, with numerous African countries set to expand vaccine coverage at unprecedented levels. | ||
=====First malaria vaccine slashes early childhood mortality===== | |||
[https://www.science.org/content/article/first-malaria-vaccine-slashes-early-childhood-deaths by Meredith Wadman 24/10/23 Science] | |||
In a major analysis in Africa, the first vaccine approved to fight malaria cut deaths among young children by 13% over nearly 4 years, the World Health Organization (WHO) reported last week. The huge evaluation of a pilot rollout of the vaccine, called RTS,S or Mosquirix and made by GlaxoSmithKline, also showed a 22% reduction in severe malaria in kids young enough to receive a three-shot series. | |||
